Alteogen Inc.

Biotech firm developing next-gen ADCs and biobetters with proprietary platform technologies.

196170 | KO

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: South Korea
Address:: 대전광역시 유성구 유성대로1628번길 62 (전민동 461-38번지), 대전광역시
Website:: http://www.alteogen.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Alteogen Inc. is a biotechnology company focused on the research and development of next-generation biopharmaceuticals, including long-acting biobetters, antibody-drug conjugates (ADCs), and biosimilars. The company leverages a portfolio of proprietary platform technologies to improve existing biologic therapies. Its core technologies include Hybrozyme™, which enables the conversion of intravenous formulations to subcutaneous injections for enhanced patient convenience; NexP™ Fusion, a technology for creating long-acting biologics; and NexMab™, an ADC platform designed for superior stability and efficacy. Through these innovations, Alteogen aims to deliver therapies with enhanced efficacy, durability, and safety profiles.

This is a Fraction of the Available Data.

You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for Alteogen Inc. and 9,000+ other companies.

Stop analyzing yesterday's news. Start building a real-time advantage.

Request Enterprise API Access

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Alteogen Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Alteogen Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Cosma Spolka Akcyjna Produces natural hemp supplements and pharmaceutical raw materials for retail & wholesale markets.	Poland	COS
COSMO Pharmaceuticals N.V. Specialty pharma for gastroenterology/dermatology, offering colon treatments & manufacturing services.	Netherlands	COPN
Crossject Develops needle-free auto-injectors for rapid drug delivery in medical emergencies.	France	ALCJ
CTC BIO, INC. Develops pharmaceuticals and feed additives for human and animal health using fermentation tech.	South Korea	060590
Cuorips Inc. Develops iPS cell therapies, like a cardiomyocyte sheet for severe heart failure.	Japan	4894
curacle co., ltd. Developing drugs for intractable diseases like diabetes caused by vascular damage and aging.	South Korea	365270
Curevac Pioneering mRNA technology to create vaccines and therapies for infectious diseases, cancer, and more.	Germany	CVAC
Curocell Inc. Biotech developing enhanced CAR-T therapies for cancer using its OVIS™ platform.	South Korea	372320
Cyfuse Biomedical K.K.	Japan	4892
Daebonglsco.,Ltd Develops raw materials and APIs for the personal care, pharmaceutical, and food industries.	South Korea	078140